Proprietary Nasal Delivery Formulation of Diazepam Developed by Particle Sciences Reaches NDA
- Written by ACN Newswire
CLEVELAND, Ohio, Nov 5, 2018 - (ACN Newswire) - The Lubrizol Corporation announces a proprietary nasal delivery formulation of diazepam for the treatment of epilepsy which was developed by contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has been submitted as a New Drug Application...